amino acids (heterocyclic amines) of the category of amino-methylimidazo-quinoline occurring in human foodstuffs as a result of inappropriate heat processing of meat (LOPRIENO et al. 1991; ADAMSON et al. 1996) are considered to be the most serious. 2-amino-3-methylimidazo [4,5-f] quinoline (IQ) in the isolated form has been used as another reference mutagen. The third reference mutagen in the present study is N-nitroso-N-methylurea (MNU) which is an important carcinogenic N-nitroso compound; in contrast to IQ and AFB 1 it is a directly acting carcinogen requiring no metabolic activation. This compound is all the more hazardous as it can be formed endogenously as demonstrated by SANDER (1971) and by MIRVISH et al. (1973) . MNU participates in the induction of brain tumors and other tumors of nerve tissue, kidney, the urinary bladder, lungs, and stomach. It also plays a role in the mammary tumor formation as demonstrated in mice, as well as in the occurrence of thyroid gland tumors (IARC 1978) .
On the other hand, certain bioactive components of plant foodstuffs can inhibit, retard, or even reverse individual steps of the process of carcinogenesis. The majority of such substances have in addition anti-oxidative and antiinflammatory effects and can be applied, consequently; as effective chemopreventive or chemoprotective agents. While mutagenic and co-mutagenic substances may occur in foodstuffs as well as in the ambient air, antimutagens can act only through their intake in foodstuffs (HAYATSU et al. 1988) .
Ellagic acid (EA), a dimer of gallic acid, belongs to the polyphenols. It is found mainly in fruit (strawberries, raspberries, grapes, black currant) as well as in various species of nuts. It has antimutagenic and anti-carcinogenic properties ( VAN LIESHOUT et al. 1998; LOARCA-PINA et al. 1996 SURH 1999) . Through its anti-oxidative effect (COZZI et al. 1995) and decreasing of cytochrome P450 activity (AHN et al. 1996) , it reduces the metabolic activation of carcinogenic substances. It also increases the activity of glutathione-S-transferase and inhibits damage to DNA (BARCH et al. 1995) . It markedly reduces the mutagenic activity of aflatoxin B 1 (LOARCA-PINA et al. 1996 .
In the present paper, we studied the effect of ellagic acid on the mutagenicity of AFB 1 , IQ, and MNU followed by the Ames test as well as by the micronucleus test, and its effect on natural immunity in mice followed by the chemiluminescence test.
MATERIAL AND METHODS
The Ames test. We evaluated the antimutagenic effect of ellagic acid on mutagens in vitro using the Ames test (AMES 1971; AMES et al. 1975; MARON & AMES 1983; ČERNÁ et al. 1989) . The test was performed according to the standard methodology (ČERNÁ et al. 1989) . The testing strains used in the present study were auxotrophic his bacterial strains of Salmonella typhimurium TA98 and TA100. S9 fraction of liver homogenate from laboratory rats induced by a mixture of polychlorinated biphenyls Delor was used for metabolic activation of indirect mutagens (IQ and AFB 1 ).
Mutagenic substances were applied at the following concentrations: IQ at concentrations of 0.1 µg, 0.01 µg and 0.001 µg per plate for strain TA98; at concentrations of 10 µg, 1 µg and 0.1 µg per plate for strain TA100; AFB 1 at concentrations of 10 µg, 1 µg and 0.1 µg per plate for both strains, TA98 and TA100; MNU at concentrations of 1000 µg, 100 µg and 10 µg per plate for strain TA100 only as these concentrations had no effect on strain TA98. Each concentration of the individual mutagens was combined with four different concentrations of ellagic acid (300, 30, 3, and 0.3 µg per plate). Each combination of a mutagen and ellagic acid was tested in two separate experiments with three plates in each experiment.
Effect of ellagic acid was expressed as percentage of inhibition of mutagenic activity following the formula:
(number of revertants of mutagen -number of revertants of mutagen with antimutagen) number of revertants of mutagen Experimental animals. All in vivo experiments (bone marrow micronucleus test and chemiluminescence test) were carried out on ten-week-old male Balb C mice, each weighing 22-26 g, purchased from BIOTEST (Konárovi-ce, Czech Republic). These animals were divided into groups containing 7-10 mice. Both experiments were performed on the same animals.
Application of substances tested. Ellagic acid was applied to mice 3 times in one-day intervals at doses of 4 g/kg for the combination with AFB 1 or IQ, and at doses of 2 g/kg for the combination with MNU. The mutagens were applied in a single dose on the third day, 1-1.5 h after the application of ellagic acid, AFB 1 at the the dose of 1 mg/kg, IQ at the dose of 20 mg/kg, and MNU at the dose of 20 mg/kg. The substances tested were applied to mice per os by gavage. In all the experiments, each respective substance was dissolved in 7% DMSO and applied in volumes of 0.1 ml/10 g of murine body weight. Equal amounts of solvent (7% DMSO) were applied to the control group. All chemicals were purchased from Sigma.
The mutagenic effects of the substances and their mixtures were evaluated in vivo using of the micronucleus test (SCHMID 1975) .
For the follow up of the effect of ellagic acid on the immune reaction of mutagen-treated mice, the chemiluminescence test (DE CHATELET et al. 1982; THOMAS et al. 1988; ŠESTÁKOVÁ et al. 1997 ) was used.
The micronucleus test. The micronucleus test is a method used for the detection of substances with a clastogenic effect, i.e. the capacity to induce the breakage of chromosomes. An increased frequency of micronuclei in polychromatophilic erythrocytes in comparison with control groups indicates that the substance tested induces chromosomal damage in nucleated erythrocytes in the bone marrow. A total of 1000 polychromatophilic erythrocytes were scored per animal by the same observer for the evaluation of the frequencies of micronucleated polychromatophilic erythrocytes. Each experiment was run three times. For the statistical analysis, Student's t-test was used.
The chemiluminescence test. The importance of chemiluminescence tests lies in the possibility of following the influence of individual substances on the production of free radicals of oxygen in polymorphonuclear leucocytes. This capability influences the potential of an increased effect of inflammatory reactions and phagocytosis in relation to bacterial cells but it simultaneously increases the risk of the action of free radicals under an insufficient anti-oxidative protection. The induction of oxygen radicals is important in relation to the atherogenic as well as to the oncogenic processes.
The chemiluminescence test detects the production of free oxygen radicals, namely of hydrogen peroxide in the complex hydrogen peroxide -myeloperoxidase -halide cofactor. The chemiluminescence value reflects the degree of phagocytosis of zymosan particles by murine granulocytes. Four groups of mice were examined: a group treated with mutagen, a group treated with ellagic acid, a group treated with mutagen and ellagic acid, and an untreated control group. In all the groups of experiments performed, the reactions of granulocytic pooled cultures from 10 or at least 7 animals, were mutually compared. The time dependence of chemiluminescence values in each group of mice was followed and the maximum values of curves obtained are presented in figures.
The chemiluminescence test was performed according to the modification of ŠESTAKOVÁ et al. (1997) . Polymorphonuclear leucocytes were obtained from the peritoneum of ten mice (per one test) four hours after the application of 5 ml glycogen. After the washing procedure, the final concentration of cells was adjusted to 5.75 × 10 6 /ml in Hanks solution at pH 7.3. In each polystyrene tube were blended 0.4 ml Hanks solution, 0.1 ml dilute luminol (3.5 mg luminol in 2 ml DMSO is diluted 1:10 in redistilled water), 0.4 ml cell suspension, and 0.1 ml 1% zymosan as stimulant (0.1 ml Hanks solution in controls). Chemiluminescence activity was measured at room temperature at 5-min intervals over a period of 90 min in an analytical luminometer. Results are presented in maximum values (mV) of the chemiluminescence response of polymorphonuclear leucocytes in the dependence on time.
RESULTS
The Ames test. All the mutagens revealed a dose dependent mutagenic activity in the Ames test (Tables 1-3 ). The two highest doses of ellagic acid (EA), i.e. 30 and 300 µg/plate, showed an obvious antimutagenic activity in this test. In strain TA98, these two concentrations reduced the mutagenic activity of IQ (0.1 µg/plate) by 56 and 72%, respectively; the mutagenicity of 0.01 µg IQ per plate was decreased by 75 and 86%, respectively, the effect of the smallest dose of IQ (0.001 µg/plate) was inhibited by 57 and 62%, respectively. In strain TA100, the two highest concentrations of ellagic acid reduced the mutagenic activity of the individual doses of IQ as follows: the effect of 10 µg/ plate by 90 and 86%, 1 µg/ plate by 81 and 73%, and that of 0.1 µg/plate by 41 and 29%. In strain TA100, the concentration of 30 µg/plate had a greater effect on mutagenity of all concentrations of IQ than that of 300 µg/plate; in strain TA98, the most effective concentration was 300 µg/plate (Table 1) .
A similar effect -a higher efficiency of 30 µg of ellagic acid than that of 300 µg/plate, was observed with all the tested concentrations of AFB 1 in both strains ( Table 2 ). The mutagenicity of 10 µg AFB 1 was reduced, respectively, by 30 and 300 µg/plate of ellagic acid by 56 and 36% in TA98, by 57 and 34% in TA100; the activity of 1 µg AFB 1 by 63 and 54% in TA98, and by 73 and 57% in TA100. Mutagenicity of the lowest concentration of AFB 1 , i.e. 0.1 µg/plate, was inhibited by 51 and 41% (TA98), and by 47 and 23% in TA100 in comparison with the activities of the respective doses of the mutagen alone. The antimu- tagenic effect of the two lowest concentrations of ellagic acid (0.3 and 3 µg/plate) was not significant except for certain concentrations of AFB 1 (1 µg/plate) in TA98 and TA100. The mutagenicity of the direct mutagen MNU at its highest concentration of 1000 µg/plate was not influenced by ellagic acid; only at lower concentrations (100 and 10 µg per plate) it was reduced in the range of 11-33%. The antimutagenic activity was generally lower than that against indirect mutagens and was the most effective at the lowest concentration of MNU, i.e. 10 µg/plate (Table 3) .
The micronucleus test. No significant increase in the frequency of micronuclei in the control mice treated by DMSO was observed in comparison with intact animals. The number of micronuclei in animals influenced by ellagic acid alone did not differ from that of the control group. In the groups of animals treated with individual mutagens, a statistically significant higher number of micronuclei in polychromatophilic erythrocytes of the bone marrow was found in comparison with the control group.
On oral application of the combination of three doses of ellagic acid (4 g/kg ) and a single dose of aflatoxin B 1 (1 mg/kg) the number of micronuclei in polychromatophilic MNU + ellagic acid (20 mg/kg + 3 × 2 g/kg) 13.5** 2.7
* significantly higher number of micronuclei as compared with the negative control (DMSO) * * significantly lower number of micronuclei as compared with mutagen alone SD = standard deviation erythrocytes was lower to a statistically significant degree in comparison with the laboratory mice treated with AFB 1 alone.
A similar effect was observed on application of the IQ mutagen: ellagic acid in combination with the IQ mutagen (3 × 4 g/kg + 20 mg/kg) reduced its mutagenic effect to a statistically significant degree. Similarly the treatment of mice with a combination of ellagic acid and MNU (3 × 2 g/kg + 20 mg/kg) led to a significant reduction of the number of micronuclei in comparison with the number of micronuclei induced by MNU alone. The results are presented in Table 4 .
The chemiluminescence test. In all experiments, four groups of animals were examined: groups of animals treated with the mutagens, with ellagic acid alone, with their combinations, and the control group.
As to the effect of the combination of ellagic acid (4 g/kg) and AFB 1 , in the group of mice treated with AFB 1 , reduced chemiluminescence values (except for the first examination) were observed in comparison with the control group and the two other groups of mice (P < 0.01). Markedly elevated chemiluminescence values were found in the group of mice treated with a combination of AFB 1 and ellagic acid as compared to the control group (P < 0.01; 29 th day, P < 0.05). In the group of mice treated with ellagic acid alone, a less marked increase in chemiluminescence was observed in comparison with the control group (3 rd and 8 th days, P < 0.01; 1 st and 11 th days, P < 0.05) ( Fig. 1 and Table 5 ). these groups did not differ significantly ( Fig. 3 and Table 7).
DISCUSSION
There are numerous papers confirming the antimutagenic effect of ellagic acid. The inhibitory effect on mutagenicity induced by AFB 1 in the Ames test was described by MANDAL et al. (1987) , GÓRSKI et al. (1991) , LOARCA-PINA et al. (1996 ), and SONI et al. (1997 . However, FRANCIS et al. (1989) observed only a small reduction of AFB 1 mutagenicity although the mutagenicity of N-methyl-N′-nitro-N-nitrosoguanidine was reduced markedly. Similarly, the mutagenic effect of IQ was markedly reduced by the action of ellagic acid (AYRTON et al. 1992) . EA was effective in inhibiting the mutagenicity of MNU in the reaction of double-stranded DNA with MNU (DIXIT & GOLD 1986 . However, CHEN and CHUNG (2000) did not find any antimutagenic effect of ellagic acid regarding the direct mutagens 2-nitrofluorene, 4,4′-dinitro-2-biphenylamine, 1-nitropyrene, 1,3-dinitropyrene, 2-nitro-pphenylenediamine, 3-nitro-o-phenylenediamine, and 4-nitro-o-phenylenediamine. Similarly, ellagic acid had no influence on the genotoxicity of 1-nitropyrene and 1,6-dinitropyrene (KUO et al. 1992) .
The induction of micronuclei and chromosomal aberrations produced by the whole-body exposure to ionizing radiation in mice was found to be significantly inhibited by oral administration of ellagic acid at 200 µmol/kg b. w. (THRESIAMMA et al. 1998) . A 3-day exposure to ellagic acid greatly reduced the degree of chromosome instability in papilomavirus-transformed cells (STICH et al. 1990 ).
According to our results, EA similarly inhibited the mutagenic effects of AFB 1 , IQ and MNU in mice after a three-day exposure as revealed by a significant reduction of the number of micronuclei in the bone marrow in the groups of mice treated with EA and mutagen in comparison with the mice treated with mutagen only.
As concerns the effect of the combination of ellagic acid (4 g/kg) and IQ, on treatment of mice with the strong mutagen and carcinogen IQ significantly reduced chemiluminescence values were found as compared to controls from the fifth day of investigations. Again, markedly increased chemiluminescence values were recorded in the group treated with ellagic acid in combination with IQ, and even with ellagic acid alone in comparison with the controls during 12 days from the begining of investigation (P < 0.01) (Fig. 2 and Table 6 ).
As to the effect of ellagic acid (2 g/kg) and MNU: during 25 days of investigation, in comparison with the controls, there was a marked decrease of chemiluminescence after the application of MNU to mice. Chemiluminescence values in the group of mice treated with ellagic acid alone differed significantly from the control group only on the first day of investigation (P < 0.01). In the group of mice treated with ellagic acid in combination with MNU, significant differences were found in comparison with the controls on the first and fourth day of investigation (P < 0.01). From the 11 th day, the results of chemiluminescence in Ellagic acid which belongs to polyphenolic compounds has anticarcinogenic and anti-oxidative effects (DE MEIJA et al. 1999; MASUDA et al. 1999) . Ellagic acid can contribute to the prevention of carcinogenesis by a more effective detoxication through an increased glutathione-S-transferase (GST) activity. Increased levels of glutathione and GST activity upon the application of ellagic acid to rodents were observed by VAN LIESHOUT et al. (1998) and GRAEME- SHEPARD et al. (2000) . ANDERSON et al. (2001) described the possibility of enhancing the antiteratogenic potential by polyphenols from nuts, especially by ellagic acid which effectively inhibited the oxidation of LDL.
In our experiments, ellagic acid acted as an effective antimutagen at the two highest concentrations tested, i.e. 300 µg and 30 µg per plate, as it significantly reduced the activity of IQ in both strains of S. typhimurium in the Ames test. The concentration of 300 µg per plate had the strongest effect in strain TA98 whereas in strain TA100, 30 µg per plate was more effective than 300 µg per plate. The concentrations of 3.0 and 0.3 µg per plate proved to be ineffective in our experiments. Also in combination with AFB 1 , ellagic acid proved to be a strong antimutagen at the two highest concentrations followed. In this case, the lower of the two concentrations, i.e. 30 µg per plate, had a much greater antimutagenic effect than that of 300 µg per plate. Similar results were observed with all concentrations of the mutagen and in both strains. It was only in combination with the direct mutagen MNU that ellagic acid did not show any marked antimutagenic effects at most of the concentrations tested in strain TA100. The highest concentrations of ellagic acid reduced the mutagenic effect of MNU weakly and only in combination with two lower concentrations of MNU.
Our results of the Ames test that show a greater effect of ellagic acid on the mutagenity of indirect mutagens than on MNU are an evidence for a more pronounced effect of ellagic acid on the activation of promutagen although other mechanisms may also play a role. MNU as a direct mutagen was applied in relatively high concentrations that manifested mutagenicity in strain TA100 only, and the lower effect of ellagic acid on this mutagen may be the results of these concentrations. A somewhat greater effect of ellagic acid was observed at the lowest concentration of MNU. On the other hand, the effect of ellagic acid on mutagenity of indirect mutagens does not seem to depend on the concentration of the mutagen applied.
Aflatoxin B 1 as a strong mutagen and carcinogen has also immunosuppressive effects in several animal species. Inhibition of phagocytic activity was observed by MICHAEL et al. (1973) in chick cells, by RICHARD and THURSTON (1975) in rabbit macrophages, and by TUREK et al. (1994) in murine granulocytes. Similarly, upon the application of aminoacid pyrolysates formed during a hightemperature treatment of meat, we observed a reduced phagocytic activity in mice as measured by chemiluminescence (TUREK et al. 1994) . Heterocyclic amines are transformed enzymatically to reactive substances and such reactions are controlled by anti-oxidants such as polyphenols, sulforafans, isothiocyanates, etc. (WEISBURGER 1999) .
In the present paper, we followed the reaction of mice treated with ellagic acid and AFB 1 , IQ, and MNU as measured by the chemiluminescence test which reflects the degree of phagocytosis by murine granulocytes. Upon the application of three different mutagens, we found, in agreement with findings in the literature, a marked inhibition of oxygen radical formation, namely of the complex: hydrogen peroxide -myeloperoxidase -halide factor in the case of AFB 1 and IQ, except for the first day of investigation, i.e. 24 h after the application of mutagen. In the experiment with ellagic acid in combination with AFB 1 , ellagic acid alone at the dose of 4 g/kg stimulated chemiluminescence values most markedly on the third and eighth day of the experiment. This result is in agreement with the finding of the stimulation of the production of the superoxide radical by ellagic acid in murine peritoneal macrophages (KAUL & KHANJUDA 1999) . Ellagic acid applied together with AFB 1 stimulated chemiluminescence to a greater degree than ellagic acid alone, namely up to 1.6 times in comparison with controls. Similar results were recorded upon the treatment of mice with ellagic acid and IQ. Ellagic acid stimulated chemiluminescence most markedly in combination with IQ up to the 12 th day of investigation (up to 1.9 times compared to controls). Different results were obtained upon the application of ellagic acid (2 g/kg) in combination with MNU. Ellagic acid alone stimulated the reaction of murine granulocytes on the 1 st day only, and ellagic acid in combination with MNU on the 1 st and 4 th day of investigation in this case.
From the results obtained it follows that ellagic acid effectively prevented the negative effects of mutagens in one of the phases of phagocytosis as measured by chemiluminescence. At the dose of 4 g/kg, ellagic acid in combination with mutagens stimulated the reaction of murine granulocytes more than ellagic acid alone. It is possible to presume that ellagic acid at the dose of 4 g/kg reacts in the presence of strong mutagens and carcinogens by an excessive increase of the formation of the complex hydrogen peroxide -myeloperoxidase -halide factor which is responsible for the lethal reaction in phagocytes. At the dose of 2 g/kg, ellagic acid alone as well as in combination with MNU had a predominantly immunomodulatory effect.
We may suppose that ellagic acid has protective effects as an antimutagenic and anticarcinogenic factor found in plant foods that can be used as a potent cancer chemopreventive agent in the diet, this possibly being caused, among others, by a favourable influence on immune processes.
významně redukovala počty mikrojader indukované samotnými mutageny v polychromatofilních erytrocytech myší. Chemiluminescenční test na myších granulocytech prokázal, že kyselina elagová nejen zabraňuje inhibičnímu účinku mutagenů na tvorbu volných kyslíkových radikálů a peroxidu vodíku, ale jejich tvorbu v kombinaci s mutageny stimuluje dokonce ve vyšším rozsahu, než je stimulace samotnou kyselinou elagovou. Z těchto výsledků vyvozujeme, že kyselina elagová silně reparuje imunosupresivní efekt testovaných mutagenů.
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